Cyanotech Corporation Retains Guerrant Associates as Its Investor Relations Counsel.Business Editors/Health/Medical Writers KAILUA KONA, Hawaii--(BUSINESS WIRE)--Sept. 29, 2003 Cyanotech Corporation (Nasdaq:CYAN), a world leader in producing high-value natural products from microalgae, today announced that it has retained Guerrant Associates to provide investor relations Investor relations The process by which the corporation communicates with its investors. and corporate communications services for the Company. Guerrant Associates will work to increase awareness of Cyanotech's corporate focus and growth strategy among investors and financial media and will provide full-service Investor Relations, strategic counseling, corporate communications, proactive outreach to the investment community, broker meetings and media relations. "Cyanotech's management and Board of Directors are committed to enriching shareholder value," stated Gerald Cysewski, Ph.D., chairman, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Cyanotech. "In addition to focusing our corporate resources on a return to profitability, we have retained Guerrant Associates as our Investor Relations counsel. We believe that Guerrant Associates' extensive network of contacts will greatly assist us in expanding our visibility within the investment community, and the firm's expertise in corporate communications will enable us to strengthen the communication of our vision and strategy to investors." To be added to Cyanotech's investor email list, please contact Laura Guerrant of Guerrant Associates at lguerrant@guerrantir.com. About Cyanotech Cyanotech Corporation, a world leader in microalgae technology, produces high-value natural products from microalgae and is the world's largest commercial producer of natural astaxanthin (pronounced "asta-zan-thin") from microalgae. Products include BioAstin(R) natural astaxanthin, a powerful antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene with expanding application as a human nutraceutical; NatuRose(R) natural astaxanthin for the aquaculture aquaculture, the raising and harvesting of fresh- and saltwater plants and animals. The most economically important form of aquaculture is fish farming, an industry that accounts for an ever increasing share of world fisheries production. and animal feed industries; Spirulina spirulina Any cyanobacteria in the genus Spirulina. A traditional food source in parts of Africa and Mexico, spirulina is an exceptionally rich source of vitamins, minerals, and protein, and one of the few nonanimal sources of vitamin B12. Pacifica(R), a nutrient-rich dietary supplement; and phycobiliproteins, which are fluorescent pigments used in the immunological diagnostics market. Spirulina Pacifica and BioAstin are sold directly online through the Company's website, www.nutrex-hawaii.com, as well as through resellers worldwide in over 30 countries. Corporate and product information is available at www.cyanotech.com. "Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, forecasts of sales in future periods, changes in sales levels to our largest customers, weather patterns, risks associated with the acceptance of new products, competition, foreign exchange fluctuations, government regulation, and other factors more fully detailed in the Company's recent Form 10-Q Form 10-Q See 10-Q. and annual form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion